Perhaps MHRA told NP he would hear their decision early next week. If so, it is perhaps possible that we received EUA from FDA today, but that all parties agreed to hold up a formal PR until MHRA concluded their decision process, thereby ensuring a coordinated announcement regarding the allocation/distribution of leronlimab between two countries.